A team built from the industry we serve, not around it

For 25 years, a member of our team served as Quality Director for a major French pharmaceutical Marketing Authorisation Holder, commissioning supplier audits, managing external audit providers, implementing audit findings and taking responsibility for the compliance decisions that followed.

That experience gives us a genuine understanding of what clients need from an audit because we have sat on the receiving end of them for a quarter of a century.

Our commercial leadership includes more than a decade in senior client-facing and key account roles at one of the pharmaceutical industry's most established GxP audit providers.

During that time, our team worked directly with more than 500 pharmaceutical companies, sold thousands of individual audits and personally built approximately one-third of that provider's audit library from the ground up.

They also transformed France into one of its strongest-performing markets.

Across our wider commercial team, we have worked with a further 1,250 pharmaceutical clients, driven significant commercial growth throughout the DACH region and generated multi-million dollar revenues across the United States market.

These are not theoretical market insights. They are the result of decades of delivering measurable commercial success across Europe and North America.

Our team includes the production leadership behind a competitor's audit business as it scaled beyond 1,000 completed audit reports.

That experience includes personally overseeing the delivery of thousands of audit reports from initial completion through CAPA management to formal audit closure, ensuring quality, consistency and reliability throughout the entire process.

Our wider operational team contributes a further decade of hands-on audit delivery experience across thousands more reports, providing the operational depth required to deliver complex audit programmes at scale.

Beyond auditing, our leadership also brings extensive Regulatory Affairs experience, including leading an international market expansion programme into Ireland for a major multinational pharmaceutical organisation.

This broader regulatory perspective strengthens our understanding of the commercial and compliance environments in which our clients operate.

Our Chief Technology Officer brings extensive senior technical leadership experience to the development of ClaripHy™ GxP's technology platform.

Our systems are designed to make audits faster, more efficient and easier to manage without compromising the professional judgement that pharmaceutical quality demands.

While many organisations are moving towards AI-generated compliance outputs, we believe technology should support experienced professionals, not replace them. Pharmaceutical quality remains, first and foremost, a human responsibility.